Task: Answer the multiple-choice question.
Question: Which drug exhibits a 6.189% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a Cc1ccc(CN2CCC(n3nccc3NC(=O)C3CCOC3)CC2)cc1C
b COc1ccc(C(=O)Nc2ccc(N3CCCC3)cc2)cc1Br
Answer: b. COc1ccc(C(=O)Nc2ccc(N3CCCC3)cc2)cc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C(=O)Nc2ccc(N3CCCC3)cc2)cc1Br
COc1ccc(C(=O)Nc2ccc(N3CCCC3)cc2)cc1Br
3-bromo-4-methoxy-N-(4-pyrrolidin-1-ylphenyl)benzamide